Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Working with transmissible spongiform encephalopathy agents.

Paul Brown1, Christian R Abee

  • 1National Institutes of Health, Bethesda, Maryland, USA.

ILAR Journal
|January 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Journal of diabetes science and technology·2026
Same author

Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.

Journal of neuro-oncology·2026
Same author

Placenta Percreta Treated by Uterine Artery Embolization, with Fatal Outcome: A Case Report.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Expectation as a Risk for Covid-19-Related Olfactory Changes: Observations From the California Farmworkers Health Survey.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Long-term tumor control after Gamma Knife radiosurgery for sporadic vestibular schwannoma.

Journal of neurosurgery·2026
Same author

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Nature medicine·2026

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are protein-misfolding illnesses. This review covers precautions for handling these agents due to their resistance and durability.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biochemistry

Background:

  • Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are a group of fatal neurodegenerative disorders affecting both humans and animals.
  • These diseases are characterized by the misfolding of normal cellular proteins into pathogenic amyloid multimers, classifying them as protein-misfolding diseases.
  • The unique resistance and environmental stability of TSE agents pose significant challenges for disinfection and containment.

Purpose of the Study:

  • To review the nature of transmissible spongiform encephalopathy (TSE) agents.
  • To discuss the implications of their resistance and durability for biosafety.
  • To outline precautions and regulations for handling TSE agents in research and clinical settings.

Main Methods:

Related Experiment Videos

  • Literature review of scientific publications on TSEs and prion diseases.
  • Analysis of existing biosafety guidelines and regulations relevant to TSE agents.
  • Discussion of the properties of prion proteins and their pathogenic mechanisms.

Main Results:

  • TSE agents are unique pathogens causing neurodegenerative diseases through protein misfolding.
  • These agents exhibit extreme resistance to standard disinfection protocols and remarkable environmental persistence.
  • The US Department of Agriculture has classified the agent of bovine spongiform encephalopathy as a bioterrorism security threat.

Conclusions:

  • Handling TSE agents requires stringent biosafety measures due to their inherent resistance and durability.
  • Comprehensive precautions and regulations are essential for protecting personnel and the environment from TSE contamination.
  • Further research into the precise nature of these agents may lead to improved containment and therapeutic strategies.